Hiroyuki Suzuki

Chiba University

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (23)

Collaborators (5)

Hidetaka Akita

Tohoku University

Hiroshi Tanaka

Tokyo Institute of Technology

Yasuhiro OHSHIMA

National Institutes for Quantum and Radiological Science and Technology

Yasushi Arano

Chiba University

Tadashi Watabe

Osaka University

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Hiroyuki Suzuki

Research Interests

Explore related searches

Contact this professor

Articles (23)

Collaborators (5)

Hidetaka Akita

Hiroshi Tanaka

Yasuhiro OHSHIMA

Yasushi Arano

Tadashi Watabe

Make your next move.

Hiroyuki Suzuki

Research Interests

Explore related searches

Contact this professor

Articles (23)

Precision targeting of the melanocortin-1 receptor with radiopharmaceuticals in metastatic melanoma

Antibody-dependent cellular cytotoxicity of anti-programmed death-ligand 1 antibodies for T cells attenuate their antitumor efficacy in a murine tumor model

An 211At-labeled alpha-melanocyte stimulating hormone peptide analog for targeted alpha therapy of metastatic melanoma

Evaluation of the Gly-Phe-Lys Linker to Reduce the Renal Radioactivity of a [64Cu]Cu-Labeled Multimeric cRGD Peptide

In vivo stable 211At-labeled prostate-specific membrane antigen-targeted tracer using a neopentyl glycol structure

Development of a neopentyl 211At‐labeled activated ester providing in vivo stable 211At‐labeled antibodies for targeted alpha therapy.

Reduction of the hepatic radioactivity levels of [111In]In-DOTA–labeled antibodies via cleavage of a linkage metabolized in lysosomes

Reduction of the hepatic radioactivity levels of [<sup>111</sup>In]In-DOTA-labeled antibodies via cleavage of a linkage metabolized in lysosomes

Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies

Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies

Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics

Neopentyl glycol-based radiohalogen-labeled amino acid derivatives for cancer radiotheranostics

Novel astatine (211At)-labelled prostate-specific membrane antigen ligand with a neopentyl-glycol structure: evaluation of stability, efficacy, and safety using a prostate cancer xenograft model

Investigation of a Radio-Iodinated Alpha-Mangostin for Targeting Estrogen Receptor Alpha (ERα) in Breast Cancer: In Silico Design, Synthesis, and Biological Evaluation

Reduction of the Renal Radioactivity of 111In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes

Reduction of the Renal Radioactivity of <SUP>111</SUP>In-DOTA-Labeled Antibody Fragments with a Linkage Cleaved by the Renal Brush Border Membrane Enzymes

Stability Estimation of Gallium Complexes of DOTA Derivatives for Radiotheranostic Applications

Delivery of aPD-L1 antibody to i.p. tumors via direct penetration by i.p. route: Beyond EPR effect

Neopentyl Glycol as a Scaffold to Provide Radiohalogenated Theranostic Pairs of High In Vivo Stability

Enhancing the Therapeutic Effect of 2-211At-astato-α-methyl-L-phenylalanine with Probenecid Loading

Copper-64-Labeled Antibody Fragments for Immuno-PET/Radioimmunotherapy with Low Renal Radioactivity Levels and Amplified Tumor-Kidney Ratios

Renal Handling of 99mTc-Labeled Antibody Fab Fragments with a Linkage Cleavable by Enzymes on Brush Border Membrane

Zn Complex of Diaminedithiol Tetradentate Ligand as a Stable Precursor for <sup>99m</sup>Tc-Labeled Compounds

Collaborators (5)

Hidetaka Akita

Hiroshi Tanaka

Yasuhiro OHSHIMA

Yasushi Arano

Tadashi Watabe

Make your next move.